GLAXOSMITHKLINE PHARMACEUTICAL (GLAXO)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 761.66 956.99 805.26 929.80 814.65 1,010.77 949.42 974.37 805.17 979.94 1,041.26 995.30
YOY Revenue Growth % -5.92% 4.38% 0.37% 18.08% 6.96% 5.62% 17.9% 4.79% -1.16% -3.05% 9.67% 2.15%
Other Income 36.44 28.21 28.11 29.83 35.64 34.54 35.07 40.68 43.72 33.57 32.12 35.95
Total Income 798.10 985.20 833.37 959.63 850.29 1,045.31 984.49 1,015.05 848.89 1,013.51 1,073.38 1,031.25
Total Expenses + 480.07 404.27 361.31 510.01 427.07 453.53 395.82 656.48 569.91 662.15 691.43 658.15
Cost of Materials Consumed 158.41 91.21 90.95 204.60 138.23 148.96 97.48 115.23 128.06 115.13 79.90 113.06
Employee Benefit Expense 165.00 145.21 141.35 172.83 151.28 150.71 124.74 152.97 152.57 138.05 151.88 164.75
Other Expenses 156.66 167.85 129.01 132.58 137.56 153.86 173.60 136.27 113.69 150.63 154.22 135.62
Operating Profit 281.59 552.72 443.95 419.79 387.58 557.24 553.60 317.89 235.26 317.79 349.83 337.15
OPM % 37% 57.8% 55.1% 45.1% 47.6% 55.1% 58.3% 32.6% 29.2% 32.4% 33.6% 33.9%
Profit Before Tax + 180.98 299.16 65.43 270.62 249.40 343.81 308.10 358.57 278.98 354.00 399.93 373.10
Tax Expense 48.73 81.65 19.71 76.14 67.07 91.31 78.22 95.70 73.97 96.51 104.31 95.24
Tax % 26.9% 27.3% 30.1% 28.1% 26.9% 26.6% 25.4% 26.7% 26.5% 27.3% 26.1% 25.5%
Profit After Tax 132.25 217.51 45.72 194.48 182.33 252.50 229.88 262.87 205.01 257.49 295.62 277.86
EPS (Basic) 7.04 12.84 9.89 11.48 10.76 14.67 13.57 15.52 12.10 15.07 16.54 16.40

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 3,749.21 3,453.71 3,251.72 3,278.03 3,198.86 3,224.38 3,128.12
YOY Revenue Growth % 8.56% 6.21% -0.8% 2.47% -0.79% 3.08% -
Other Income 145.93 122.59 100.66 75.78 110.58 79.01 102.32
Total Income 3,895.14 3,576.30 3,352.38 3,353.81 3,309.44 3,303.39 3,230.44
Total Expenses + 2,639.95 1,755.66 1,590.04 1,771.14 1,662.85 1,733.64 1,855.87
Cost of Materials Consumed 499.90 545.17 427.48 611.18 472.02 474.38 686.57
Employee Benefit Expense 579.70 624.39 594.99 610.23 614.69 628.55 537.20
Other Expenses 601.29 586.10 567.57 549.73 576.14 630.71 632.10
Operating Profit 1,109.26 1,698.05 1,661.68 1,506.89 1,536.01 1,490.74 1,272.25
OPM % 29.6% 49.2% 51.1% 46% 48% 46.2% 40.7%
Profit Before Exceptional 1,255.19 959.80 837.37 767.47 723.10 647.24 653.97
Exceptional Items 4.69 -143.61 -0.97 11.58 -172.60 -341.49 28.69
Profit Before Tax + 1,259.88 816.19 836.40 779.05 550.50 305.75 682.66
Tax Expense 332.30 226.23 225.71 -915.67 192.35 212.55 237.27
Tax % 26.4% 27.7% 27% -117.5% 34.9% 69.5% 34.8%
Profit After Tax 927.58 589.96 610.69 1,694.72 358.15 93.20 445.39
EPS (Basic) 54.52 34.83 36.05 100.04 21.14 5.50 26.29

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 502.19 544.56 618.36 0.00 0.00 0.00 0.00
Property, Plant & Equipment 269.54 296.80 294.81 0.00 0.00 0.00 0.00
Capital Work in Progress 14.32 13.93 20.31 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 13.33 23.55 34.09 0.00 0.00 0.00 0.00
Current Assets + 3,605.89 3,012.06 2,708.22 0.00 0.00 0.00 0.00
Inventories 481.74 525.05 459.97 0.00 0.00 0.00 0.00
Trade Receivables 292.55 222.06 192.38 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 538.85 64.17 34.94 0.00 0.00 0.00 0.00
Current Investments 1,000.00 813.22 518.29 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 169.41 169.41 169.41 0.00 0.00 0.00 0.00
Other Equity 1,781.90 1,608.23 1,571.87 0.00 0.00 0.00 0.00
Non-Current Liabilities 251.60 254.03 258.94 0.00 0.00 0.00 0.00
Current Liabilities 1,905.17 1,524.95 1,326.36 0.00 0.00 0.00 0.00
Total Liabilities 2,156.77 1,778.98 1,585.30 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 1,289.91 582.00 484.23 810.74 0.00 0.00 0.00
Cash from Investing Activities -45.81 8.72 807.85 -405.50 0.00 0.00 0.00
Cash from Financing Activities -769.42 -561.49 -1,543.33 -524.24 0.00 0.00 0.00
Net Increase/Decrease in Cash 474.68 29.23 -251.25 -119.00 0.00 0.00 0.00